Shopping Cart
Remove All
Your shopping cart is currently empty
Senlizumab is a human-derived antibody expressed in CHO cells, targeting TNFSF2/TNFa. It features a huIgG4SP heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 146.9 kDa. For its isotype control, refer to HumanIgG4kappa, Isotype Control.

| Description | Senlizumab is a human-derived antibody expressed in CHO cells, targeting TNFSF2/TNFa. It features a huIgG4SP heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 146.9 kDa. For its isotype control, refer to HumanIgG4kappa, Isotype Control. |
| Synonyms | CDP-571, BAY-103356 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | TNFSF2/TNFa |
| Cas No. | 336128-48-4 |
| Isotype | IgG4 (S228P) |
| Recommended Isotype Control |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.